Citation: J. Rosenau et al., Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation - possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection, J HEPATOL, 34(6), 2001, pp. 895-902
Authors:
Schlitt, HJ
Barkmann, A
Boker, KHW
Schmidt, HHJ
Emmanouilidis, N
Rosenau, J
Bahr, MJ
Tusch, G
Manns, MP
Nashan, B
Klempnauer, J
Citation: Hj. Schlitt et al., Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study, LANCET, 357(9256), 2001, pp. 587-591
Authors:
Tippner, C
Nashan, B
Hoshino, K
Schmidt-Sandte, E
Akimaru, K
Boker, KHW
Schlitt, HJ
Citation: C. Tippner et al., Clinical and subclinical acute rejection early after liver transplantation- Contributing factors and relevance for the long-term course, TRANSPLANT, 72(6), 2001, pp. 1122-1128
Authors:
Boker, KHW
Pehle, B
Steinmetz, C
Breitenstein, K
Bahr, M
Lichtinghagen, R
Citation: Khw. Boker et al., Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis, HEP-GASTRO, 47(33), 2000, pp. 812-819
Authors:
Barkmann, A
Nashan, B
Schmidt, HHJ
Boker, KHW
Emmanouilidis, N
Rosenau, J
Bahr, MJ
Hoffmann, MW
Manns, MP
Klempnauer, J
Schlitt, HJ
Citation: A. Barkmann et al., Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil, TRANSPLANT, 69(9), 2000, pp. 1886-1890
Authors:
Trautwein, C
Possienke, M
Schlitt, HJ
Boker, KHW
Horn, R
Raab, R
Manns, MP
Brabant, G
Citation: C. Trautwein et al., Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation, AM J GASTRO, 95(9), 2000, pp. 2343-2351
Authors:
Tillmann, HL
Trautwein, C
Bock, T
Boker, KHW
Jackel, E
Glowienka, M
Oldhafer, K
Bruns, I
Gauthier, J
Condreay, LD
Raab, HR
Manns, MP
Citation: Hl. Tillmann et al., Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation, HEPATOLOGY, 30(1), 1999, pp. 244-256
Authors:
Schofl, C
Ponczek, M
Mader, T
Waring, M
Benecke, H
Von zur Muhlen, A
Mix, H
Cornberg, M
Boker, KHW
Manns, MP
Wagner, S
Citation: C. Schofl et al., Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes, AM J P-GAST, 39(1), 1999, pp. G164-G172
Authors:
Wedemeyer, H
Boker, KHW
Pethig, K
Petzold, DR
Flemming, P
Tillmann, HL
Vollmar, J
Basturk, M
Goldmann, E
Griffin, KE
Haverich, A
Manns, MP
Citation: H. Wedemeyer et al., Famciclovir treatment of chronic hepatitis B in heart transplant recipients: A prospective trial, TRANSPLANT, 68(10), 1999, pp. 1503-1511
Authors:
Tietge, UJF
Boker, KHW
Bahr, MJ
Weinberg, S
Pichlmayr, R
Schmidt, HHJ
Manns, MP
Citation: Ujf. Tietge et al., Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation, HEP-GASTRO, 45(24), 1998, pp. 2255-2260
Authors:
Rambusch, EG
Nashan, B
Tillmann, HL
Boker, KHW
Schlitt, HJ
Maschek, H
Raab, R
Manns, MP
Citation: Eg. Rambusch et al., Hepatitis B de-novo infection following liver transplantation indicating the need for active hepatitis B immunization of liver transplant candidates, Z GASTROENT, 36(12), 1998, pp. 1027-1035